Brunda Ganneru

1.4k total citations
9 papers, 235 citations indexed

About

Brunda Ganneru is a scholar working on Infectious Diseases, Immunology and Virology. According to data from OpenAlex, Brunda Ganneru has authored 9 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Immunology and 3 papers in Virology. Recurrent topics in Brunda Ganneru's work include SARS-CoV-2 and COVID-19 Research (3 papers), HIV Research and Treatment (3 papers) and Immunotherapy and Immune Responses (3 papers). Brunda Ganneru is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), HIV Research and Treatment (3 papers) and Immunotherapy and Immune Responses (3 papers). Brunda Ganneru collaborates with scholars based in United States, India and Sweden. Brunda Ganneru's co-authors include Margherita Rosati, Viraj Kulkarni, George N. Pavlakis, Candido Alicea, Barbara K. Felber, Kate E. Broderick, Niranjan Y. Sardesai, Rashmi Jalah, Antonio Valentin and Rachel Kelly Beach and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Brunda Ganneru

8 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brunda Ganneru United States	7	132	89	73	60	45	9	235
Anton M. Sholukh United States	6	116 0.9×	120 1.3×	92 1.3×	47 0.8×	50 1.1×	17	241
Ane Ogbe United Kingdom	9	188 1.4×	98 1.1×	117 1.6×	66 1.1×	44 1.0×	16	337
Jim Ackland United States	6	93 0.7×	81 0.9×	67 0.9×	80 1.3×	90 2.0×	10	259
Nicola Winstone United Kingdom	4	131 1.0×	136 1.5×	53 0.7×	100 1.7×	72 1.6×	4	237
Simone I. Richardson South Africa	11	195 1.5×	157 1.8×	100 1.4×	90 1.5×	51 1.1×	22	350
K. Rachael Parks United States	6	85 0.6×	49 0.6×	214 2.9×	90 1.5×	19 0.4×	8	297
Harini Natarajan United States	7	102 0.8×	60 0.7×	125 1.7×	50 0.8×	45 1.0×	10	243
Li Ren China	9	87 0.7×	92 1.0×	62 0.8×	102 1.7×	65 1.4×	33	252
Lynn Baglyos United States	7	154 1.2×	256 2.9×	92 1.3×	89 1.5×	108 2.4×	7	319
John D. Ventura United States	9	98 0.7×	150 1.7×	127 1.7×	52 0.9×	51 1.1×	11	252

Countries citing papers authored by Brunda Ganneru

Since Specialization

Citations

This map shows the geographic impact of Brunda Ganneru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brunda Ganneru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brunda Ganneru more than expected).

Fields of papers citing papers by Brunda Ganneru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brunda Ganneru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brunda Ganneru. The network helps show where Brunda Ganneru may publish in the future.

Co-authorship network of co-authors of Brunda Ganneru

This figure shows the co-authorship network connecting the top 25 collaborators of Brunda Ganneru. A scholar is included among the top collaborators of Brunda Ganneru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brunda Ganneru. Brunda Ganneru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Vadrevu, Krishna Mohan, Amit Kumar Chawla, Bharath Chakravarthy, et al.. (2025). A double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority & lot to lot consistency of single component oral cholera vaccine BBV131 (Hillchol®) in comparison to Shanchol™. Vaccine. 55. 126998–126998.

Vadrevu, Krishna Mohan, Brunda Ganneru, Siddharth Reddy, et al.. (2022). Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants. Scientific Reports. 12(1). 12038–12038. 22 indexed citations

Yadav, Pragya D., Sreelekshmy Mohandas, Anita M. Shete, et al.. (2022). Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model. iScience. 25(10). 105178–105178. 5 indexed citations

Vadrevu, Krishna Mohan, Siddharth Reddy, Harsh Jogdand, et al.. (2022). Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study. The Lancet Infectious Diseases. 22(9). 1303–1312. 21 indexed citations

Kulkarni, Viraj, Margherita Rosati, Rashmi Jalah, et al.. (2014). DNA vaccination by intradermal electroporation induces long‐lasting immune responses in rhesus macaques. Journal of Medical Primatology. 43(5). 329–340. 11 indexed citations

Jalah, Rashmi, Margherita Rosati, Brunda Ganneru, et al.. (2013). The p40 Subunit of Interleukin (IL)-12 Promotes Stabilization and Export of the p35 Subunit. Journal of Biological Chemistry. 288(9). 6763–6776. 62 indexed citations

Kulkarni, Viraj, Margherita Rosati, Antonio Valentin, et al.. (2013). HIV-1 p24gag Derived Conserved Element DNA Vaccine Increases the Breadth of Immune Response in Mice. PLoS ONE. 8(3). e60245–e60245. 40 indexed citations

Jalah, Rashmi, Vainav Patel, Viraj Kulkarni, et al.. (2012). IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques. Human Vaccines & Immunotherapeutics. 8(11). 1620–1629. 54 indexed citations

Kulkarni, Viraj, Rashmi Jalah, Brunda Ganneru, et al.. (2010). Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques. Vaccine. 29(39). 6742–6754. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact